Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy. - Portocarrero-Bonifaz A; Syed S; Kassel M; McKenzie GW; Shah VM; Forry BM; Gaskins JT; Sowards KT; Avula TB; Masters A; Schneider JG; Silva SR (PloS one, 2025)